EUROJECT

Serial Number 79337295
Registration 7282176
700

Registration Progress

Application Filed
Dec 28, 2021
Under Examination
Approved for Publication
Nov 7, 2023
Published for Opposition
Nov 7, 2023
Registered
Jan 23, 2024

Basic Information

Serial Number
79337295
Registration Number
7282176
Filing Date
December 28, 2021
Registration Date
January 23, 2024
Published for Opposition
November 7, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 23, 2024
Registration
Registered
Classes
010

Rights Holder

UNITHER PHARMACEUTICALS

34
Address
151 rue André Durouchez,
Espace Industriel Nord, CS 28028 F-80084
FR

Ownership History

UNITHER PHARMACEUTICALS

Original Applicant
99
FR

UNITHER PHARMACEUTICALS

New Owner Before Publication #1
34
FR

UNITHER PHARMACEUTICALS

Owner at Publication
34
FR

UNITHER PHARMACEUTICALS

Original Registrant
34
FR

Legal Representation

Attorney
Todd A. Denys
USPTO Deadlines 2 active
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
MAINTENANCE
Section 8 (6-Year) Declaration Due (Based on registration date 2024-01-23)
R.PRA Jan 23, 2030 1661 days Critical No
MAINTENANCE
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2024-01-23)
R.PRA Jan 23, 2034 3122 days Critical No
Next deadline: Section 8 (6-Year) Declaration Due (Based on registration date 2024-01-23) on January 23, 2030 (1661 days)

Application History

35 events
Date Code Type Description
May 13, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2024 FIMP P FINAL DISPOSITION PROCESSED
Apr 24, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Apr 23, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 7, 2023 PUBO A PUBLISHED FOR OPPOSITION
Nov 6, 2023 GPNX P NOTIFICATION PROCESSED BY IB
Oct 18, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 18, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 18, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 3, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2023 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 29, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 28, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 13, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 13, 2023 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 31, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 31, 2023 GNFR O FINAL REFUSAL E-MAILED
Mar 31, 2023 CNFR R FINAL REFUSAL WRITTEN
Mar 24, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 4, 2023 RFNT P REFUSAL PROCESSED BY IB
Dec 14, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 14, 2022 RFRR P REFUSAL PROCESSED BY MPU
Oct 4, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 3, 2022 CNRT R NON-FINAL ACTION WRITTEN
Sep 30, 2022 DOCK D ASSIGNED TO EXAMINER
Apr 19, 2022 MAFR O APPLICATION FILING RECEIPT MAILED
Apr 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2022 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 7, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 010
Medical apparatus and instruments for injection being injection devices for pharmaceuticals, injection needles, injection syringes; injectors for medical use, namely, medical fluid injectors; injection devices for pharmaceutical products being injection devices for pharmaceuticals; containers for medical samples, namely, capillary tubes for samples for medical use, medical specimen collection cups for the collection of urine; syringes for medical use; injection needles for medical and surgical use; needle holders for surgical use being attachments for medical injection devices to aid holding injection needles perpendicular to the skin; none of the aforesaid goods for urological application or in the form of flexible cannulas

Active Deadlines

Section 8 (6-Year) Declaration Due (Based on registration date 2024-01-23)
Due: Jan 23, 2030
Grace Period Until: Jul 23, 2030
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2024-01-23)
Due: Jan 23, 2034
Grace Period Until: Jul 23, 2034

Additional Information

Pseudo Mark
EURO INJECT

Classification

International Classes
010